GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » YoY EBITDA Growth

RushNet (RushNet) YoY EBITDA Growth : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is RushNet YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. RushNet's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

RushNet's EBITDA per Share for the three months ended in . 20 was $0.00.

RushNet YoY EBITDA Growth Historical Data

The historical data trend for RushNet's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet YoY EBITDA Growth Chart

RushNet Annual Data
Trend
YoY EBITDA Growth

RushNet Quarterly Data
YoY EBITDA Growth

RushNet YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

RushNet's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

YoY EBITDA Growth (A: . 20 )
=(EBITDA per Share (A: . 20 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

RushNet's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RushNet YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of RushNet's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » YoY EBITDA Growth
Comparable Companies
MOJO LBIX KRED FTFT CRVP JSDA TRUU WTER REED LTEA BRFH NBEV CELH PRMW DYDIF OCVLF LSDAF RFFRY COT COKE
Traded in Other Exchanges
N/A
Address
8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
Website
https://www.rushnetinc.com
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.